Richard McGowan
Chairman en TECHPRECISION CORPORATION .
Fortuna: 150 548 $ al 31/03/2024
Perfil
Richard S.
McGowan is currently the Non-Executive Chairman at Techprecision Corp.
He previously served as the Chairman at Cleveland BioLabs, Inc. from 2015 to 2016.
Prior to that, he worked as Counsel at Weitz & Luxenberg PC from 1995 to 2009.
Additionally, he held the position of President & Partner at SFB Holding NV from 2000 to 2008.
Mr. McGowan obtained his undergraduate degree from Stony Brook University and his graduate degree from Boston University School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/10/2023 | 41 703 ( 0.48% ) | 150 548 $ | 31/03/2024 |
Cargos activos de Richard McGowan
| Empresas | Cargo | Inicio |
|---|---|---|
| TECHPRECISION CORPORATION | Chairman | 31/03/2017 |
Antiguos cargos conocidos de Richard McGowan.
| Empresas | Cargo | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Chairman | 08/07/2016 |
Weitz & Luxenberg PC
 Weitz & Luxenberg PC Miscellaneous Commercial ServicesCommercial Services Weitz & Luxenberg PC is a plaintiff's law firm established in 1986. The private company is based in New York, NY. The firm is the largest mass tort and personal injury litigation law firm in the United States and has won over $17 billion in verdicts and settlements for clients from all 50 states. With over 100 attorneys, Weitz & Luxenberg advocates for those injured by negligence and is rated #1 by U.S. News & World Report for 2017. | General Counsel | 01/01/2009 |
| SFB Holding NV | President | 01/01/2008 |
Formación de Richard McGowan.
| Stony Brook University | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
| Techprecision Corp. | |
Weitz & Luxenberg PC
Weitz & Luxenberg PC Miscellaneous Commercial ServicesCommercial Services Weitz & Luxenberg PC is a plaintiff's law firm established in 1986. The private company is based in New York, NY. The firm is the largest mass tort and personal injury litigation law firm in the United States and has won over $17 billion in verdicts and settlements for clients from all 50 states. With over 100 attorneys, Weitz & Luxenberg advocates for those injured by negligence and is rated #1 by U.S. News & World Report for 2017. | Commercial Services |
| SFB Holding NV |
- Bolsa de valores
- Insiders
- Richard McGowan
